跳至主要内容
临床试验/CTRI/2018/02/012216
CTRI/2018/02/012216已完成4 期

Tramadol sparing effect of 0.5% ropivacaine versus 2% lignocaine in preoperative stellate ganglion block in upper limb orthopaedic surgeries.

Department of Anaesthesia and intensive care0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patiens scheduled for upper limb orthopaedic surgery.
  • 2.ASA physical status 1 and 2 of either sex.
  • 3.Age between 18 to 60 years.
  • 4.BMI between 18 to 30 kilogram per metre square

排除标准

  • 1.Patients refusal for the procedure.
  • 2.Patients having haemodynamic instability.
  • 3.Patients with coagulopathy and bleeding disorders.
  • 4.Preexisting peripheral neuropathy.
  • 5.Preexisting local infection at the site of block.
  • 6.Patients having history of drug or substance abuse.
  • 7.Inability to understand functioning of PCA pump and VAS.
  • 8.Contraindication to study drugs lignocaine, ropivacaine and tramadol.
  • 9.Patients on chronic pain management drugs.
  • 10.Patients with simultaneous acute postoperative pain other parts of the body.
  • 11.Contraindication to general anesthesia.

研究者

发起方
Department of Anaesthesia and intensive care

相似试验